UA78300C2 - Method for manufacture of sertindole - Google Patents

Method for manufacture of sertindole Download PDF

Info

Publication number: UA78300C2
Authority: UA; Ukraine
Prior art keywords: fluorophenyl; chloroindole; mol; ethylenediamine; copper
Prior art date: 2002-03-27

Application number

UA20041008714A

Other languages

English (en)

Ukrainian (uk)

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-27

Filing date

2003-03-26

Publication date

2007-03-15

2003-03-26 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2007-03-15 Publication of UA78300C2 publication Critical patent/UA78300C2/uk

Links

238000000034 method Methods 0.000 title claims abstract description 47
GZKLJWGUPQBVJQ-UHFFFAOYSA-N sertindole Chemical compound C1=CC(F)=CC=C1N1C2=CC=C(Cl)C=C2C(C2CCN(CCN3C(NCC3)=O)CC2)=C1 GZKLJWGUPQBVJQ-UHFFFAOYSA-N 0.000 title claims abstract description 13
229960000652 sertindole Drugs 0.000 title claims abstract description 13
238000004519 manufacturing process Methods 0.000 title abstract description 5
238000006243 chemical reaction Methods 0.000 claims abstract description 57
MYTGFBZJLDLWQG-UHFFFAOYSA-N 5-chloro-1h-indole Chemical compound ClC1=CC=C2NC=CC2=C1 MYTGFBZJLDLWQG-UHFFFAOYSA-N 0.000 claims abstract description 47
JYEKQDWSLSXYTJ-UHFFFAOYSA-N 5-chloro-1-(4-fluorophenyl)indole Chemical compound C1=CC(F)=CC=C1N1C2=CC=C(Cl)C=C2C=C1 JYEKQDWSLSXYTJ-UHFFFAOYSA-N 0.000 claims abstract description 26
239000003446 ligand Substances 0.000 claims abstract description 26
150000001879 copper Chemical class 0.000 claims abstract description 17
230000003197 catalytic effect Effects 0.000 claims abstract description 15
150000001450 anions Chemical class 0.000 claims abstract description 11
VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical compound [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 claims abstract description 8
JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 claims abstract description 5
AITNMTXHTIIIBB-UHFFFAOYSA-N 1-bromo-4-fluorobenzene Chemical group FC1=CC=C(Br)C=C1 AITNMTXHTIIIBB-UHFFFAOYSA-N 0.000 claims description 32
PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 32
-1 4-fluorophenyl halide Chemical class 0.000 claims description 17
239000002585 base Substances 0.000 claims description 15
238000002360 preparation method Methods 0.000 claims description 13
150000004649 carbonic acid derivatives Chemical group 0.000 claims description 10
230000002411 adverse Effects 0.000 claims description 9
230000003993 interaction Effects 0.000 claims description 9
150000001875 compounds Chemical class 0.000 claims description 7
229910052739 hydrogen Inorganic materials 0.000 claims description 7
239000001257 hydrogen Substances 0.000 claims description 7
239000002253 acid Substances 0.000 claims description 6
150000005045 1,10-phenanthrolines Chemical class 0.000 claims description 5
229910019142 PO4 Inorganic materials 0.000 claims description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
SSJXIUAHEKJCMH-UHFFFAOYSA-N cyclohexane-1,2-diamine Chemical compound NC1CCCCC1N SSJXIUAHEKJCMH-UHFFFAOYSA-N 0.000 claims description 4
235000021317 phosphate Nutrition 0.000 claims description 4
150000003013 phosphoric acid derivatives Chemical class 0.000 claims description 4
KGNQDBQYEBMPFZ-UHFFFAOYSA-N 1-fluoro-4-iodobenzene Chemical compound FC1=CC=C(I)C=C1 KGNQDBQYEBMPFZ-UHFFFAOYSA-N 0.000 claims description 3
125000003118 aryl group Chemical group 0.000 claims description 3
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 2
229910052783 alkali metal Inorganic materials 0.000 claims description 2
150000001340 alkali metals Chemical class 0.000 claims description 2
150000004679 hydroxides Chemical class 0.000 claims description 2
125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
238000012876 topography Methods 0.000 claims 1
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 118
239000000203 mixture Substances 0.000 description 47
238000003756 stirring Methods 0.000 description 42
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 32
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 31
239000002904 solvent Substances 0.000 description 25
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 24
238000004128 high performance liquid chromatography Methods 0.000 description 24
239000000243 solution Substances 0.000 description 20
239000012044 organic layer Substances 0.000 description 18
238000001816 cooling Methods 0.000 description 14
239000000126 substance Substances 0.000 description 14
239000012043 crude product Substances 0.000 description 13
239000000047 product Substances 0.000 description 13
238000010992 reflux Methods 0.000 description 13
238000004458 analytical method Methods 0.000 description 12
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
239000010410 layer Substances 0.000 description 10
239000011521 glass Substances 0.000 description 9
238000004821 distillation Methods 0.000 description 8
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 7
239000003054 catalyst Substances 0.000 description 7
229910052802 copper Inorganic materials 0.000 description 7
239000010949 copper Substances 0.000 description 7
238000003786 synthesis reaction Methods 0.000 description 7
LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 6
238000006254 arylation reaction Methods 0.000 description 6
230000015572 biosynthetic process Effects 0.000 description 6
238000002347 injection Methods 0.000 description 6
239000007924 injection Substances 0.000 description 6
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
SSJXIUAHEKJCMH-PHDIDXHHSA-N (1r,2r)-cyclohexane-1,2-diamine Chemical compound N[C@@H]1CCCC[C@H]1N SSJXIUAHEKJCMH-PHDIDXHHSA-N 0.000 description 4
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
229910021529 ammonia Inorganic materials 0.000 description 4
239000012074 organic phase Substances 0.000 description 4
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
238000009835 boiling Methods 0.000 description 3
MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
239000012467 final product Substances 0.000 description 3
230000010354 integration Effects 0.000 description 3
230000008569 process Effects 0.000 description 3
239000012047 saturated solution Substances 0.000 description 3
239000012086 standard solution Substances 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 2
125000000217 alkyl group Chemical group 0.000 description 2
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
229910052921 ammonium sulfate Inorganic materials 0.000 description 2
235000011130 ammonium sulphate Nutrition 0.000 description 2
230000000561 anti-psychotic effect Effects 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
125000004429 atom Chemical group 0.000 description 2
239000006227 byproduct Substances 0.000 description 2
ZJRWDIJRKKXMNW-UHFFFAOYSA-N carbonic acid;cobalt Chemical compound [Co].OC(O)=O ZJRWDIJRKKXMNW-UHFFFAOYSA-N 0.000 description 2
239000007795 chemical reaction product Substances 0.000 description 2
229910000001 cobalt(II) carbonate Inorganic materials 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
238000004817 gas chromatography Methods 0.000 description 2
239000012535 impurity Substances 0.000 description 2
239000012299 nitrogen atmosphere Substances 0.000 description 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
239000011541 reaction mixture Substances 0.000 description 2
230000009257 reactivity Effects 0.000 description 2
150000003346 selenoethers Chemical class 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000007858 starting material Substances 0.000 description 2
230000002194 synthesizing effect Effects 0.000 description 2
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 2
125000003161 (C1-C6) alkylene group Chemical group 0.000 description 1
RJCGZNCCVKIBHO-UHFFFAOYSA-N 1-chloro-4-fluorobenzene Chemical compound FC1=CC=C(Cl)C=C1 RJCGZNCCVKIBHO-UHFFFAOYSA-N 0.000 description 1
DNWUJWKXSPBDCF-UHFFFAOYSA-N 5-bromo-1-(4-fluorophenyl)indole Chemical compound C1=CC(F)=CC=C1N1C2=CC=C(Br)C=C2C=C1 DNWUJWKXSPBDCF-UHFFFAOYSA-N 0.000 description 1
CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 description 1
208000019901 Anxiety disease Diseases 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
206010013654 Drug abuse Diseases 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
238000006887 Ullmann reaction Methods 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
230000036506 anxiety Effects 0.000 description 1
150000001500 aryl chlorides Chemical class 0.000 description 1
150000001502 aryl halides Chemical class 0.000 description 1
238000010533 azeotropic distillation Methods 0.000 description 1
235000010216 calcium carbonate Nutrition 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
239000007809 chemical reaction catalyst Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000000460 chlorine Substances 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
208000010877 cognitive disease Diseases 0.000 description 1
238000010668 complexation reaction Methods 0.000 description 1
229940125782 compound 2 Drugs 0.000 description 1
238000006482 condensation reaction Methods 0.000 description 1
RYGMFSIKBFXOCR-OUBTZVSYSA-N copper-65 Chemical compound [65Cu] RYGMFSIKBFXOCR-OUBTZVSYSA-N 0.000 description 1
150000004985 diamines Chemical class 0.000 description 1
SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
238000007865 diluting Methods 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000000694 effects Effects 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
238000010812 external standard method Methods 0.000 description 1
229910052736 halogen Inorganic materials 0.000 description 1
150000002367 halogens Chemical group 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
244000144980 herd Species 0.000 description 1
150000002431 hydrogen Chemical class 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
150000002475 indoles Chemical class 0.000 description 1
238000009776 industrial production Methods 0.000 description 1
239000002050 international nonproprietary name Substances 0.000 description 1
CBEQRNSPHCCXSH-UHFFFAOYSA-N iodine monobromide Chemical compound IBr CBEQRNSPHCCXSH-UHFFFAOYSA-N 0.000 description 1
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
238000002955 isolation Methods 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
229910052753 mercury Inorganic materials 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
238000003541 multi-stage reaction Methods 0.000 description 1
238000007040 multi-step synthesis reaction Methods 0.000 description 1
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000001624 naphthyl group Chemical group 0.000 description 1
150000002825 nitriles Chemical class 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
125000004433 nitrogen atom Chemical group N* 0.000 description 1
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
239000012038 nucleophile Substances 0.000 description 1
239000012071 phase Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
235000011181 potassium carbonates Nutrition 0.000 description 1
238000002203 pretreatment Methods 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
238000004064 recycling Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
238000007086 side reaction Methods 0.000 description 1
235000011182 sodium carbonates Nutrition 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
238000012289 standard assay Methods 0.000 description 1
208000011117 substance-related disease Diseases 0.000 description 1
HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
230000009466 transformation Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Psychiatry (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Indole Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Catalysts (AREA)
Plural Heterocyclic Compounds (AREA)

UA20041008714A 2002-03-27 2003-03-26 Method for manufacture of sertindole UA78300C2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200200480		2002-03-27
PCT/DK2003/000208 WO2003080597A1 (fr)	2002-03-27	2003-03-26	Procede de fabrication de sertindole

Publications (1)

Publication Number	Publication Date
UA78300C2 true UA78300C2 (en)	2007-03-15

Family

ID=37952025

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UA20041008714A UA78300C2 (en)	2002-03-27	2003-03-26	Method for manufacture of sertindole

Country Status (17)

Country	Link
EP (2)	EP1490353A1 (fr)
JP (1)	JP2005531519A (fr)
KR (1)	KR20040095332A (fr)
CN (1)	CN100528863C (fr)
AR (1)	AR039116A1 (fr)
AU (1)	AU2003215528B2 (fr)
BR (1)	BR0308627A (fr)
CA (1)	CA2480239C (fr)
CO (1)	CO5611197A2 (fr)
EA (1)	EA007009B1 (fr)
ME (1)	MEP6008A (fr)
NZ (1)	NZ535533A (fr)
PL (1)	PL371585A1 (fr)
RS (1)	RS85004A (fr)
UA (1)	UA78300C2 (fr)
WO (1)	WO2003080597A1 (fr)
ZA (1)	ZA200408273B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003256970A1 (en) *	2002-08-02	2004-02-23	Rhodia Pharma Solutions Inc.	Copper catalyzed arylation
RU2436490C2 (ru)	2006-07-07	2011-12-20	Пласт 2000 С.Р.Л.	Заварочный аппарат (варианты)
CN101591330B (zh) *	2009-06-29	2013-03-06	上海医药工业研究院	舍吲哚晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE58370B1 (en) *	1985-04-10	1993-09-08	Lundbeck & Co As H	Indole derivatives
SK285410B6 (sk) *	1997-05-09	2007-01-04	H. Lundbeck A/S	Spôsob výroby sertindolu a medziproduktov
WO1999018057A1 (fr) *	1997-10-06	1999-04-15	Massachusetts Institute Of Technology	Preparation de diaryl ethers par reactions de condensation

2003
- 2003-03-24 AR ARP030101015A patent/AR039116A1/es unknown
- 2003-03-26 AU AU2003215528A patent/AU2003215528B2/en not_active Ceased
- 2003-03-26 EP EP03744772A patent/EP1490353A1/fr not_active Ceased
- 2003-03-26 KR KR10-2004-7015339A patent/KR20040095332A/ko not_active Ceased
- 2003-03-26 EP EP05023338A patent/EP1661887A1/fr not_active Withdrawn
- 2003-03-26 ME MEP-60/08A patent/MEP6008A/xx unknown
- 2003-03-26 CA CA2480239A patent/CA2480239C/fr not_active Expired - Fee Related
- 2003-03-26 NZ NZ535533A patent/NZ535533A/en not_active IP Right Cessation
- 2003-03-26 PL PL03371585A patent/PL371585A1/xx not_active Application Discontinuation
- 2003-03-26 EA EA200401261A patent/EA007009B1/ru not_active IP Right Cessation
- 2003-03-26 UA UA20041008714A patent/UA78300C2/uk unknown
- 2003-03-26 RS YU85004A patent/RS85004A/sr unknown
- 2003-03-26 BR BR0308627-5A patent/BR0308627A/pt not_active IP Right Cessation
- 2003-03-26 JP JP2003578351A patent/JP2005531519A/ja active Pending
- 2003-03-26 WO PCT/DK2003/000208 patent/WO2003080597A1/fr not_active Ceased
- 2003-03-26 CN CNB038070111A patent/CN100528863C/zh not_active Expired - Fee Related
2004
- 2004-10-13 CO CO04102837A patent/CO5611197A2/es not_active Application Discontinuation
- 2004-10-13 ZA ZA200408273A patent/ZA200408273B/en unknown

Also Published As

Publication number	Publication date
CN1642942A (zh)	2005-07-20
AU2003215528B2 (en)	2009-05-28
CO5611197A2 (es)	2006-02-28
EP1490353A1 (fr)	2004-12-29
RS85004A (sr)	2006-12-15
WO2003080597A1 (fr)	2003-10-02
AU2003215528A1 (en)	2003-10-08
PL371585A1 (en)	2005-06-27
CA2480239A1 (fr)	2003-10-02
JP2005531519A (ja)	2005-10-20
CA2480239C (fr)	2010-11-23
NZ535533A (en)	2007-01-26
ZA200408273B (en)	2006-07-26
CN100528863C (zh)	2009-08-19
KR20040095332A (ko)	2004-11-12
EP1661887A1 (fr)	2006-05-31
BR0308627A (pt)	2005-02-15
MEP6008A (xx)	2010-02-10
EA007009B1 (ru)	2006-06-30
AR039116A1 (es)	2005-02-09
EA200401261A1 (ru)	2005-02-24

Publication	Publication Date	Title
CN107176955B (zh)	2019-04-09	一种巴瑞替尼的制备方法
UA78300C2 (en)	2007-03-15	Method for manufacture of sertindole
JP2022511948A (ja)	2022-02-01	１－［（３ｒ，４ｓ）－４－シアノテトラヒドロピラン－３－イル］－３－［（２－フルオロ－６－メトキシ－４－ピリジル）アミノ］ピラゾール－４－カルボキサミドの調製方法
TWI551592B (zh)	2016-10-01	以兩步驟來製備３，５－二側氧己酸酯
Kiriyama et al.	2016	Self-organization of dipyridylcalix [4] pyrrole into a supramolecular cage for dicarboxylates
KR101005969B1 (ko)	2011-01-05	4-페닐-4-옥소-2-부텐산 에스테르 유도체의 제조방법
CN116419922B (zh)	2025-05-02	一种从泊马度胺选择性合成3,6′-二硫代泊马度胺的方法
US20090264656A1 (en)	2009-10-22	Method for manufacture of sertindole
Streef et al.	1985	Reactivity of some 3‐substituted derivatives of 2, 6‐dihalogenopyridines towards potassium amide in liquid ammonia [a]
CN101133035A (zh)	2008-02-27	制备洛沙坦的方法
JP4211081B2 (ja)	2009-01-21	４−シアノピリダジン−３−オン誘導体
JP5205971B2 (ja)	2013-06-05	テトラヒドロピラン化合物の製造方法
HK1080855B (en)	2010-04-23	Method for manufacture of sertindole
Müller et al.	2005	Desymmetrization of spiro-activated meso-cyclopropanes via nucleophilic substitution
JP4899587B2 (ja)	2012-03-21	ε−カプロラクタムの製造方法
JP2007070270A (ja)	2007-03-22	３−アミノメチルオキセタン化合物の製法
CN119798218A (zh)	2025-04-11	一种e3酶配体-连接链复合物及其制备方法
CN119219536A (zh)	2024-12-31	一种钯催化制备亚磺酰基化合物的方法及其应用
EP1807401A1 (fr)	2007-07-18	Procede de preparation de phenyl 2-pyrimidinyl cetones et leurs nouveaux intermediaires
JP5151180B2 (ja)	2013-02-27	３，３’，４，４’−シクロヘキセニルフェニルテトラカルボン酸化合物群及び３，３’，４，４’−ビフェニルテトラカルボン酸化合物の製法
JP2001247508A (ja)	2001-09-11	オレフィン化合物の製造方法
JP2023158278A (ja)	2023-10-30	Ｎ－アセチルインドール化合物の製造方法
JP2002212149A (ja)	2002-07-31	フッ化テトラアルキルアンモニウムの製造方法、およびそれを用いたβ−ヒドロキシケトンの製造方法
ITMI970912A1 (it)	1998-10-18	Processo di sintesi di 1,7-diaril oppure eteroaril eptan-4-oli e nuovi intermedi di sintesi
JP2009191006A (ja)	2009-08-27	光学活性な４−アミノ−３−（３，４−ジクロロフェニル）ブタン−１−オールの製造方法およびその中間体